The correlation between IFNG and pathomics provides a valuable biomarker framework for elucidating the pathophysiology of HNSCC and may inform personalized therapeutic strategies through non-invasive characterization of the immune microenvironment. The gene discussed is IFNG; the disease is head and neck squamous cell carcinoma.